CannaPowder, Inc. (CAPD) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
20 RAOUL WALLENBERG ST., TEL AVIV,, 6971916 |
| State of Incorp. | UT |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 68,855 | 426,163 | 931,569 | 714,409 | 721,414 | 815,058 | |||
| Cash and cash equivalent | 68,855 | 426,163 | 707,395 | 606,245 | 721,414 | 815,058 | |||
| Short-term investments | 224,174 | 108,164 | |||||||
| Prepaid expense | 17,256 | 44,767 | 19,448 | 12,847 | 14,517 | 25,170 | |||
| Deposits current assets | |||||||||
| Total current assets: | 86,111 | 470,930 | 951,017 | 727,256 | 735,931 | 840,228 | |||
| Noncurrent Assets | |||||||||
| TOTAL ASSETS: | 86,111 | 470,930 | 951,017 | 727,256 | 735,931 | 840,228 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 14,021 | 5,000 | 25,159 | 800 | |||||
| Interest and dividends payable | |||||||||
| Other undisclosed accounts payable and accrued liabilities | 14,021 | 5,000 | 25,159 | 800 | |||||
| Due to related parties | |||||||||
| Other undisclosed current liabilities | (11,477) | ||||||||
| Total current liabilities: | 2,544 | 5,000 | 25,159 | 800 | |||||
| Noncurrent Liabilities | |||||||||
| Other undisclosed noncurrent liabilities | 14,021 | ||||||||
| Total noncurrent liabilities: | 14,021 | ||||||||
| Total liabilities: | 16,565 | 5,000 | 25,159 | 800 | |||||
| Equity | |||||||||
| Equity, attributable to parent, including: | 86,111 | 454,365 | 946,017 | 702,097 | 735,931 | 839,428 | |||
| Common stock | 124 | 120 | 109 | 105 | 99 | 99 | |||
| Additional paid in capital | 5,944,356 | 5,832,996 | 5,101,711 | 4,472,095 | 1,261,051 | 1,261,051 | |||
| Accumulated other comprehensive income (loss) | 5,338 | (650) | (55,057) | (173,832) | (4,670) | (3,794) | |||
| Accumulated deficit | (5,767,260) | (5,303,116) | (4,052,346) | (3,573,378) | (498,677) | (402,741) | |||
| Other undisclosed equity, attributable to parent | (96,447) | (74,985) | (48,400) | (22,893) | (21,872) | (15,187) | |||
| Total equity: | 86,111 | 454,365 | 946,017 | 702,097 | 735,931 | 839,428 | |||
| TOTAL LIABILITIES AND EQUITY: | 86,111 | 470,930 | 951,017 | 727,256 | 735,931 | 840,228 | |||
Income Statement (P&L) (USD)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (485,355) | (1,249,737) | (489,475) | (3,090,722) | (102,621) | (188,769) | ||
| Operating loss: | (485,355) | (1,249,737) | (489,475) | (3,090,722) | (102,621) | (188,769) | ||
| Nonoperating income (expense) | (485,606) | (27,618) | (2,765) | 19,052 | ||||
| Loss, foreign currency transaction, before tax | (2,765) | |||||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Loss from continuing operations before equity method investments, income taxes: | (970,961) | (1,277,355) | (492,240) | (3,071,670) | (102,621) | (188,769) | ||
| Other undisclosed income from continuing operations before income taxes | 485,355 | |||||||
| Loss from continuing operations: | (485,606) | (1,277,355) | (492,240) | (3,071,670) | (102,621) | (188,769) | ||
| Loss before gain (loss) on sale of properties: | (485,606) | (1,277,355) | (492,240) | (3,071,670) | (102,621) | (188,769) | ||
| Other undisclosed net income (loss) | 2,765 | (19,052) | ||||||
| Net loss: | (485,606) | (1,277,355) | (489,475) | (3,090,722) | (102,621) | (188,769) | ||
| Net income attributable to noncontrolling interest | 21,462 | |||||||
| Other undisclosed net income attributable to parent | 26,585 | 10,507 | 16,021 | 6,685 | 7,235 | |||
| Net loss available to common stockholders, diluted: | (464,144) | (1,250,770) | (478,968) | (3,074,701) | (95,936) | (181,534) | ||
Comprehensive Income (USD)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (485,606) | (1,277,355) | (489,475) | (3,090,722) | (102,621) | (188,769) | ||
| Other undisclosed comprehensive income (loss) | 4,049 | 118,775 | (191,034) | 5,811 | (3,665) | |||
| Comprehensive loss: | (485,606) | (1,273,306) | (370,700) | (3,281,756) | (96,810) | (192,434) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 21,462 | 26,585 | 10,507 | 16,021 | 6,685 | 7,235 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 5,990 | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (458,154) | (1,246,721) | (360,193) | (3,265,735) | (90,125) | (185,199) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.